Related Experiment Videos
The fibroblast growth factor-binding protein FGF-BP
Shaker Abuharbeid1, Frank Czubayko, Achim Aigner
1Department of Pharmacology and Toxicology, Philipps-University School of Medicine, Marburg, Germany.
The International Journal of Biochemistry & Cell Biology
|December 6, 2005
Summary
Fibroblast growth factor-binding protein (FGF-BP) is crucial for releasing fibroblast growth factors (FGFs), promoting tumor growth and angiogenesis. Targeting FGF-BP effectively inhibits tumor progression, highlighting its therapeutic potential.
Area of Science:
- Molecular biology
- Cancer research
- Cell signaling
Background:
- Fibroblast growth factors (FGFs) regulate vital cellular processes like migration, proliferation, and differentiation.
- Heparin-binding FGFs are sequestered in the extracellular matrix by heparan sulfate proteoglycans.
- FGF-binding protein (FGF-BP) facilitates the release and bioactivation of these FGFs.
Purpose of the Study:
- To investigate the role of FGF-BP in FGF bioactivation and its implications in tumor growth and angiogenesis.
- To evaluate FGF-BP as a potential therapeutic target for anti-tumor strategies.
Main Methods:
- Analysis of FGF-BP expression patterns in various tissues and tumor models.
- Utilizing ribozymes and RNA interference (RNAi) to target FGF-BP in mouse tumor models.
- Assessing the impact of FGF-BP inhibition on tumor growth and angiogenesis.
Main Results:
- FGF-BP expression is tissue-specific and regulated by distinct promoter elements.
- FGF-BP is upregulated in tumors, particularly during early stages where angiogenesis is critical.
- Targeting FGF-BP in mouse models significantly reduced tumor growth and angiogenesis.
Conclusions:
- FGF-BP acts as a rate-limiting factor for tumor growth and functions as an angiogenic switch molecule.
- FGF-BP represents a promising molecular target for novel anti-tumor therapies.